Skip to main content
Caplight Logo









Circulate Health

Circulate Health

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://circulate.health/

Last Round

Strategic

Dec 3, 2025

Total Funding Raised

$12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Circulate Health is a biotechnology company that provides therapeutic plasma exchange (TPE) treatments to reverse aging and improve health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

therapeutic plasma exchangeTPElongevity clinicblood purificationapheresisbiohackingfunctional medicinehealthspanturnkey clinical platformbiological age reductionapheresis nursingclinical service deliveryplasma exchange therapyanti-aging medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Circulate Health Comparables

Compare Circulate Health with similar companies based on industry and business-model similarity.

Circulate Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Global Apheresis, Inc.
81%
Asahi Kasei
61%
Vibrant Practice
58%

Circulate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicDec 3, 2025
SeedJul 2, 2025

Key People

Founding team and executive leadership

Uri Greenwald

Ex-Founding CEO, Current Board Member

Founding Team

Circulate Health Investors

Notable investors and investment history

Circulate Health investors
InvestorRounds
Khosla VenturesSeed
CSC UpShot VenturesSeed
Seaside VenturesSeed
Scrum VenturesStrategic, Seed
Seaside VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 3, 2025

    Scrum Ventures participated in the strategic round.

  • Jul 2, 2025

    $12M raised in Seed round.

Circulate Health Filings

Explore SEC and related filing metadata, where available.

Circulate Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Circulate Health's valuation, stock price, and market status.

Is Circulate Health a public or private company?

Circulate Health is a private company.

What is the current stock price of Circulate Health?

Circulate Health is a private company with no public stock price. No recent secondary market data is available.

How much is Circulate Health worth (valuation)?

Valuation information for Circulate Health is not publicly available.

Can I buy Circulate Health stock?

Circulate Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Circulate Health's last funding round?

Circulate Health's most recent funding round was Seed on July 2, 2025.

Who are the main investors in Circulate Health?

Key investors in Circulate Health include Khosla Ventures.

Will Circulate Health IPO soon?

No public IPO plans have been announced for Circulate Health.

How can I track Circulate Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Circulate Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range16
Year Founded2025
Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?